ClinicalTrials.Veeva

Menu

China Diabetes Cardiovascular Initiative (CDCV)

B

Beijing Institute of Heart, Lung and Blood Vessel Diseases

Status

Unknown

Conditions

Acute Coronary Syndrome
Diabetes Mellitus

Treatments

Other: Quality improvement activities

Study type

Observational

Funder types

Other

Identifiers

NCT05037058
CDCV2021

Details and patient eligibility

About

As a collaborative project between American Heart Association, Chinese Society of Cardiology, American Diabetes Association and Chinese Diabetes Society, the China Diabetes Cardiovascular Initiative aims to enhance the attention and awareness of cardiovascular health care professionals (HCPs) in the managements of cardiovascular diseases and diabetes, to reduce diabetes-related complication and minimize adverse events in patients with cardiovascular disease, and to reduce the risk of cardiovascular morbidity and mortality in diabetic patients.

Enrollment

9,600 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patients hospitalized with acute coronary syndrome and diabetes.
  2. Aged at least 18 years.

Exclusion criteria

None

Trial contacts and locations

0

Loading...

Central trial contact

Yongchen Hao, Ph. D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems